A detailed history of Blackstone Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Blackstone Inc holds 16,485 shares of TXG stock, worth $219,909. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,485
Previous 16,485 -0.0%
Holding current value
$219,909
Previous $320,000 16.25%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$35.33 - $55.79 $318,641 - $503,170
9,019 Added 120.8%
16,485 $919,000
Q4 2022

Feb 14, 2023

BUY
$24.4 - $41.3 $182,170 - $308,345
7,466 New
7,466 $272,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.27B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Blackstone Inc Portfolio

Follow Blackstone Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blackstone Inc, based on Form 13F filings with the SEC.

News

Stay updated on Blackstone Inc with notifications on news.